Exosomes Secreted by Cardiosphere-derived Cells Reduce Scarring, Attenuate Adverse Remodelling, and Improve Function in Acute and Chronic Porcine Myocardial Infarction

Overview

Journal Eur Heart J

Publisher Oxford University Press

Specialty Cardiology & Vascular Diseases

Date 2017 Feb 4

PMID 28158410

Citations 324

Authors

Romain Gallet

James Dawkins

Jackelyn Valle

Eli Simsolo

Geoffrey de Couto

Ryan Middleton

Eleni Tseliou

Daniel Luthringer

Michelle Kreke

Rachel R Smith

Linda Marban

Bijan Ghaleh

Eduardo Marban

Affiliations

Soon will be listed here.

Abstract

Aims: Naturally secreted nanovesicles known as exosomes are required for the regenerative effects of cardiosphere-derived cells (CDCs), and exosomes mimic the benefits of CDCs in rodents. Nevertheless, exosomes have not been studied in a translationally realistic large-animal model. We sought to optimize delivery and assess the efficacy of CDC-secreted exosomes in pig models of acute (AMI) and convalescent myocardial infarction (CMI).

Methods And Results: In AMI, pigs received human CDC exosomes (or vehicle) by intracoronary (IC) or open-chest intramyocardial (IM) delivery 30 min after reperfusion. No-reflow area and infarct size (IS) were assessed histologically at 48 h. Intracoronary exosomes were ineffective, but IM exosomes decreased IS from 80 ± 5% to 61 ± 12% (P= 0.001) and preserved left ventricular ejection fraction (LVEF). In a randomized placebo-controlled study of CMI, pigs 4 weeks post-myocardial infarction (MI) underwent percutaneous IM delivery of vehicle (n = 6) or CDC exosomes (n = 6). Magnetic resonance imaging (MRI) performed before and 1 month after treatment revealed that exosomes (but not vehicle) preserved LV volumes and LVEF (−0.1 ± 2.2% vs. −5.4 ± 3.6%, P= 0.01) while decreasing scar size. Histologically, exosomes decreased LV collagen content and cardiomyocyte hypertrophy while increasing vessel density.

Conclusion: Cardiosphere-derived cell exosomes delivered IM decrease scarring, halt adverse remodelling and improve LVEF in porcine AMI and CMI. While conceptually attractive as cell-free therapeutic agents for myocardial infarction, exosomes have the disadvantage that IM delivery is necessary.

Citing Articles

Extracellular vesicles in cardiovascular homeostasis and disease: potential role in diagnosis and therapy.

Xiao J, Sluijter J Nat Rev Cardiol. 2025; .

PMID: 40045042 DOI: 10.1038/s41569-025-01141-2.

Engineered Extracellular Vesicles as a New Class of Nanomedicine.

Wen X, Hao Z, Yin H, Min J, Wang X, Sun S Chem Bio Eng. 2025; 2(1):3-22.

PMID: 39975802 PMC: 11835263. DOI: 10.1021/cbe.4c00122.

Therapeutic potential of exosomes derived from human endometrial mesenchymal stem cells for heart tissue regeneration after myocardial infarction.

Sepehri M, Rabbani S, Ai J, Bahrami N, Ghanbari H, Namini M Regen Ther. 2025; 28:451-461.

PMID: 39974600 PMC: 11836543. DOI: 10.1016/j.reth.2025.01.007.

Cardiac repair using regenerating neonatal heart tissue-derived extracellular vesicles.

Li H, Liu Y, Lin Y, Li S, Liu C, Cai A Nat Commun. 2025; 16(1):1292.

PMID: 39900896 PMC: 11790877. DOI: 10.1038/s41467-025-56384-x.

Extracellular vesicular microRNAs and cardiac hypertrophy.

Hu H, Wang X, Yu H, Wang Z Front Endocrinol (Lausanne). 2025; 15():1444940.

PMID: 39850481 PMC: 11753959. DOI: 10.3389/fendo.2024.1444940.

References

Chakravarty T, Makkar R, Ascheim D, Traverse J, Schatz R, DeMaria A . ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design. Cell Transplant. 2016; 26(2):205-214. PMC: 5657761. DOI: 10.3727/096368916X692933. View

Gray W, French K, Ghosh-Choudhary S, Maxwell J, Brown M, Platt M . Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology. Circ Res. 2014; 116(2):255-63. PMC: 4338016. DOI: 10.1161/CIRCRESAHA.116.304360. View

Quesenberry P, Aliotta J, Deregibus M, Camussi G . Role of extracellular RNA-carrying vesicles in cell differentiation and reprogramming. Stem Cell Res Ther. 2015; 6:153. PMC: 4558901. DOI: 10.1186/s13287-015-0150-x. View

Sahoo S, Klychko E, Thorne T, Misener S, Schultz K, Millay M . Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity. Circ Res. 2011; 109(7):724-8. PMC: 3201702. DOI: 10.1161/CIRCRESAHA.111.253286. View

de Couto G, Liu W, Tseliou E, Sun B, Makkar N, Kanazawa H . Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction. J Clin Invest. 2015; 125(8):3147-62. PMC: 4563759. DOI: 10.1172/JCI81321. View

Tseliou E, Reich H, de Couto G, Terrovitis J, Sun B, Liu W . Cardiospheres reverse adverse remodeling in chronic rat myocardial infarction: roles of soluble endoglin and Tgf-β signaling. Basic Res Cardiol. 2014; 109(6):443. DOI: 10.1007/s00395-014-0443-8. View

Chernyshev V, Rachamadugu R, Tseng Y, Belnap D, Jia Y, Branch K . Size and shape characterization of hydrated and desiccated exosomes. Anal Bioanal Chem. 2015; 407(12):3285-301. DOI: 10.1007/s00216-015-8535-3. View

Heusch G . Treatment of Myocardial Ischemia/Reperfusion Injury by Ischemic and Pharmacological Postconditioning. Compr Physiol. 2015; 5(3):1123-45. DOI: 10.1002/cphy.c140075. View

Heusch G, Skyschally A, Schulz R . The in-situ pig heart with regional ischemia/reperfusion - ready for translation. J Mol Cell Cardiol. 2011; 50(6):951-63. DOI: 10.1016/j.yjmcc.2011.02.016. View

10.

Johnston P, Sasano T, Mills K, Evers R, Lee S, Ruckdeschel Smith R . Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation. 2009; 120(12):1075-83, 7 p following 1083. PMC: 2848167. DOI: 10.1161/CIRCULATIONAHA.108.816058. View

11.

Malliaras K, Li T, Luthringer D, Terrovitis J, Cheng K, Chakravarty T . Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells. Circulation. 2011; 125(1):100-12. PMC: 3256094. DOI: 10.1161/CIRCULATIONAHA.111.042598. View

12.

Makkar R, Smith R, Cheng K, Malliaras K, Thomson L, Berman D . Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet. 2012; 379(9819):895-904. PMC: 4326004. DOI: 10.1016/S0140-6736(12)60195-0. View

13.

Barile L, Lionetti V, Cervio E, Matteucci M, Gherghiceanu M, Popescu L . Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc Res. 2014; 103(4):530-41. DOI: 10.1093/cvr/cvu167. View

14.

Thery C, Zitvogel L, Amigorena S . Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002; 2(8):569-79. DOI: 10.1038/nri855. View

15.

Schmidt M, Jacobsen J, Lash T, Botker H, Sorensen H . 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study. BMJ. 2012; 344:e356. PMC: 3266429. DOI: 10.1136/bmj.e356. View

16.

Malliaras K, Makkar R, Smith R, Cheng K, Wu E, Bonow R . Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). J Am Coll Cardiol. 2013; 63(2):110-22. PMC: 3947063. DOI: 10.1016/j.jacc.2013.08.724. View

17.

Malliaras K, Smith R, Kanazawa H, Yee K, Seinfeld J, Tseliou E . Validation of contrast-enhanced magnetic resonance imaging to monitor regenerative efficacy after cell therapy in a porcine model of convalescent myocardial infarction. Circulation. 2013; 128(25):2764-75. PMC: 3907064. DOI: 10.1161/CIRCULATIONAHA.113.002863. View

18.

Kanazawa H, Tseliou E, Malliaras K, Yee K, Dawkins J, de Couto G . Cellular postconditioning: allogeneic cardiosphere-derived cells reduce infarct size and attenuate microvascular obstruction when administered after reperfusion in pigs with acute myocardial infarction. Circ Heart Fail. 2015; 8(2):322-32. PMC: 4366297. DOI: 10.1161/CIRCHEARTFAILURE.114.001484. View

19.

Sahoo S, Losordo D . Exosomes and cardiac repair after myocardial infarction. Circ Res. 2014; 114(2):333-44. DOI: 10.1161/CIRCRESAHA.114.300639. View

20.

Vicencio J, Yellon D, Sivaraman V, Das D, Boi-Doku C, Arjun S . Plasma exosomes protect the myocardium from ischemia-reperfusion injury. J Am Coll Cardiol. 2015; 65(15):1525-36. DOI: 10.1016/j.jacc.2015.02.026. View